Molecular Biology in Clinical Oncology Workshop

​General Information 

Selection of Participants
The application deadline was Tuesday, March 27, 2018. The Workshop Faculty have selected a group of 50 total participants based on the materials submitted by the applicant and by the applicant’s sponsor (mentor, program supervisor, or department head; n/a for senior scientists).

Computer Requirement
All participants are required to bring a laptop to the workshop. If a participant does not have access to a laptop, they may request to borrow one for the duration of the workshop for a fee.

All participants are responsible for transportation to and from Snowmass Village, Colorado. Snowmass Village is approximately 10 miles from Aspen, Colorado.  Snowmass Village can be reached by flying into the Aspen/Pitkin County Airport or the Denver International Airport. Snowmass Village is approximately 15-20 minutes from the Aspen/Pitkin County Airport; local shuttles to/from Aspen/Pitkin Airport are provided for those staying at the Viceroy Snowmass, the conference venue. Snowmass Village is also accessible by car or shuttle from the Denver International Airport; these arrangements are the responsibility of the participant.

Workshop Materials
Participants will receive recommended reading prior to the workshop. Faculty members will provide abstracts of their talks along with suggested references. Laboratory Directors will provide a detailed syllabus of the material to be covered in their hands-on laboratory sessions. Trainees will receive access to a workshop-specific website with these course materials, recommended reading, general workshop information, reminders, and opportunities to network.

Faculty – Lecturers (as of 7/6/18)

  • Michael A. Caligiuri, City of Hope, Duarte, California
  • Charles D. Drake, Columbia University Medical Center, New York, New York
  • Jeffrey A. Engelman, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts
  • Mark W. Geraci, Indiana University, Indianapolis, Indiana
  • William C. Hahn, Dana-Farber Cancer Institute, Boston, Massachusetts
  • Carl H. June, Abramson Cancer Center of University of the Pennsylvania, Philadelphia, Pennsylvania
  • William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, Massachusetts
  • David G. Kirsch, Duke University Medical Center, Durham, North Carolina
  • Ross L. Levine, Memorial Sloan Kettering Cancer Center, New York, New York
  • Christine M. Lovly, Vanderbilt University Medical Center, Nashville, Tennessee
  • Susan N. Perkins, National Cancer Institute, Rockville, Maryland
  • Amanda J. Redig, Takeda Oncology, Cambridge, Massachusetts
  • Charles W.M. Roberts, St. Jude Children's Research Hospital, Memphis, Tennessee
  • Charles L. Sawyers (NCI Grant Project PI), Memorial Sloan Kettering Cancer Center, New York, New York
  • Jean Y. Tang, Stanford University School of Medicine, Redwood City, California
  • Barry S. Taylor, Memorial Sloan Kettering Cancer Center, New York, New York
  • Jennifer A. Wargo, The University of Texas MD Anderson Cancer Center, Houston, Texas

Faculty – Laboratories (as of 7/6/18)

Tools for Successful Gene Expression Analysis: From RNA to Real-Time RT-PCR
Camilla Heinzmann, Heinzmann Coaching & Consulting, Inc., Valencia, California
Maggie Soares, Heinzmann Coaching & Consulting, Inc., Toronto, Ontario, Canada
Sonia Dobias, QIAGEN, Inc., Valencia, California

From Proteins to Proteomics: Protein Purification, Fractionation, and System-wide Characterization

Nicholas A. Graham, University of Southern California, Los Angeles, California
Parag Mallick, Stanford University, Palo Alto, California

Next-Gen Sequencing

Amanda Gedman, Illumina, Inc., San Diego, California
Margaret Porter, Illumina, Inc., San Diego, California

Using Genomics and Bioinformatics in Cancer Research

Michael G. Edwards, Bioinfo Solutions, LLC, Parker, Colorado
Robert Stearman, Indiana University School of Medicine, Indianapolis, Indiana
Tzu Phang, University of Colorado Anschutz Medical Campus, Aurora, Colorado

CRISPR/Cas9: The Genome Editing Revolution

Leigh Brody, Desktop Genetics, London, United Kingdom

Top of page